metaproterenol sulfate · Boehringer Ingelheim · NDA 015874, 016402, 017571, 017659, 018761
Alupent
Earliest generic entry, as listed · earliest of 7 marketed strengths
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 7
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 015874 · 001 · discontinued | tablet, oral | 20MG | open |
| 015874 · 002 · discontinued | tablet, oral | 10MG | open |
| 016402 · 001 · discontinued | aerosol, metered, inhalation | 0.65MG/INH | open |
| 017571 · 001 · discontinued | syrup, oral | 10MG/5ML | open |
| 017659 · 001 · discontinued | solution, inhalation | 5% | open |
| 018761 · 001 · discontinued | solution, inhalation | 0.6% | open |
| 018761 · 002 · discontinued | solution, inhalation | 0.4% | open |